MITO Annual CFO
-$44.97 M
+$8.57 M+16.00%
31 December 2021
Summary:
As of January 24, 2025, MITO annual cash flow from operations is -$44.97 million, with the most recent change of +$8.57 million (+16.00%) on December 31, 2021. During the last 3 years, it has risen by +$27.11 million (+37.61%).MITO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Quarterly CFO
N/A
31 March 2022
Summary:
MITO quarterly cash flow from operations is not available.MITO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO TTM CFO
N/A
31 March 2022
Summary:
MITO TTM cash flow from operations is not available.MITO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.0% | - | - |
3 y3 years | +37.6% | - | - |
5 y5 years | +35.6% | - | - |
MITO Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | at high |
Stealth BioTherapeutics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$44.97 M(-16.0%) | - | - |
June 2021 | - | -$23.28 M(-46.9%) | -$67.10 M(-12.5%) |
Dec 2020 | -$53.54 M(+11.6%) | - | - |
Sept 2020 | - | -$43.82 M(+33.2%) | -$76.72 M(-11.0%) |
June 2020 | - | -$32.90 M | -$86.21 M |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | -$47.98 M(-33.4%) | - | - |
Sept 2019 | - | -$53.31 M(+4.7%) | -$53.31 M(+4.7%) |
Dec 2018 | -$72.08 M(+3.2%) | - | - |
Sept 2018 | - | -$50.91 M | -$50.91 M |
Dec 2017 | -$69.83 M(+29.3%) | - | - |
Dec 2016 | -$54.02 M | - | - |
FAQ
- What is Stealth BioTherapeutics annual cash flow from operations?
- What is the all time high annual CFO for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics annual CFO year-on-year change?
- What is the all time high quarterly CFO for Stealth BioTherapeutics?
- What is the all time high TTM CFO for Stealth BioTherapeutics?
What is Stealth BioTherapeutics annual cash flow from operations?
The current annual CFO of MITO is -$44.97 M
What is the all time high annual CFO for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high annual cash flow from operations is -$44.97 M
What is Stealth BioTherapeutics annual CFO year-on-year change?
Over the past year, MITO annual cash flow from operations has changed by +$8.57 M (+16.00%)
What is the all time high quarterly CFO for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high quarterly cash flow from operations is -$23.28 M
What is the all time high TTM CFO for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high TTM cash flow from operations is -$50.91 M